References
- Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 1997;30:403-18 https://doi.org/10.1046/j.1365-2559.1997.5460776.x
- Gill RR, Gerbaudo VH, Jacobson FL, Trotman-Dickenson B, Matsuoka S, Hunsaker A, et al. MR imaging of benign and malignant pleural disease. Magn Reson Imaging Clin N Am 2008;16:319-39 https://doi.org/10.1016/j.mric.2008.03.004
- Barreiro TJ, Katzman PJ. Malignant mesothelioma: a case presentation and review. J Am Osteopath Assoc 2006;106:699-704
- Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidermiol 1997;145:211-8 https://doi.org/10.1093/oxfordjournals.aje.a009093
- Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 2004;24:105-19 https://doi.org/10.1148/rg.241035058
- Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Ro-entgenol 1990;155:965-9 https://doi.org/10.2214/ajr.155.5.2120965
- Truong MT, Marom EM, Erasmus JJ. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging. J Thorac Imaging 2006;21:146-53 https://doi.org/10.1097/00005382-200605000-00006
- Beer TW, Buchanan R, Matthews AW, Stradling R, Pullinger N, Pethybridge RJ. Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype. Hum Pathol 1998;29:246-51 https://doi.org/10.1016/S0046-8177(98)90043-0
- Pistolesi M, Rusthoven J. Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. Chest 2004;126:1318-29 https://doi.org/10.1378/chest.126.4.1318